Your browser doesn't support javascript.
loading
Fixed-dose combination bictegravir, emtricitabine, and tenofovir alafenamide versus dolutegravir-containing regimens for initial treatment of HIV-1 infection: week 144 results from two randomised, double-blind, multicentre, phase 3, non-inferiority trials.
Orkin, Chloe; DeJesus, Edwin; Sax, Paul E; Arribas, Jose R; Gupta, Samir K; Martorell, Claudia; Stephens, Jeffrey L; Stellbrink, Hans-Jurgen; Wohl, David; Maggiolo, Franco; Thompson, Melanie A; Podzamczer, Daniel; Hagins, Debbie; Flamm, Jason A; Brinson, Cynthia; Clarke, Amanda; Huang, Hailin; Acosta, Rima; Brainard, Diana M; Collins, Sean E; Martin, Hal.
Afiliação
  • Orkin C; Queen Mary University of London, London, UK; Barts Health NHS Trust, Royal London Hospital, Ambrose King Centre, London, UK.
  • DeJesus E; Orlando Immunology Center, Orlando, FL, USA.
  • Sax PE; Division of Infectious Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  • Arribas JR; Infectious Diseases Unit, Hospital Universitario La Paz, IdiPaz Madrid, Spain.
  • Gupta SK; Department of Medicine, Division of Infectious Diseases, Indiana University School of Medicine, Indianapolis, IN, USA.
  • Martorell C; The Research Institute, Springfield, MA, USA.
  • Stephens JL; Department of Internal Medicine, Mercer University School of Medicine, Macon, GA, USA.
  • Stellbrink HJ; Department of Internal Medicine, Infectious Diseases, University of Hamburg, Hamburg, Germany.
  • Wohl D; Department of Medicine, Institute of Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Maggiolo F; Unit of HIV-related Diseases and Experimental Therapies, Azienda Ospedaliera Papa Giovanni XXIII, Bergamo, Italy.
  • Thompson MA; AIDS Research Consortium of Atlanta, Atlanta, GA, USA.
  • Podzamczer D; Infectious Disease Department, Hospital Universitari de Bellvitge, Barcelona, Spain.
  • Hagins D; Georgia Department of Public Health, Coastal Health District, Chatham Care Center, Savannah, GA, USA.
  • Flamm JA; Department of Adult and Family Medicine, Kaiser Permanente Medical Group, Sacramento, CA, USA.
  • Brinson C; Central Texas Clinical Research, Austin, TX, USA.
  • Clarke A; Elton John Centre, Royal Sussex County Hospital, Brighton & Sussex University Hospitals NHS Trust, Brighton, UK.
  • Huang H; Department of Biometrics, Gilead Sciences, Foster City, CA, USA.
  • Acosta R; Department of Virology, Gilead Sciences, Foster City, CA, USA.
  • Brainard DM; Department of HIV Clinical Research, Gilead Sciences, Foster City, CA, USA.
  • Collins SE; Department of HIV Clinical Research, Gilead Sciences, Foster City, CA, USA. Electronic address: sean.collins@gilead.com.
  • Martin H; Department of HIV Clinical Research, Gilead Sciences, Foster City, CA, USA.
Lancet HIV ; 7(6): e389-e400, 2020 06.
Article em En | MEDLINE | ID: mdl-32504574
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Adenina / Didesoxinucleosídeos / Infecções por HIV / Lamivudina / Tenofovir / Emtricitabina / Compostos Heterocíclicos de 4 ou mais Anéis / Compostos Heterocíclicos com 3 Anéis Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet HIV Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 2_ODS3 Base de dados: MEDLINE Assunto principal: Adenina / Didesoxinucleosídeos / Infecções por HIV / Lamivudina / Tenofovir / Emtricitabina / Compostos Heterocíclicos de 4 ou mais Anéis / Compostos Heterocíclicos com 3 Anéis Tipo de estudo: Clinical_trials Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Lancet HIV Ano de publicação: 2020 Tipo de documento: Article